Organogenesis Holdings (ORGO) Other Operating Expenses (2016 - 2026)

Organogenesis Holdings' Other Operating Expenses history runs 7 years deep, the most recent figure standing at $25.8 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 14.92% year-over-year to $25.8 million in Q1 2026; TTM through Mar 2026 was $413.7 million, a 694.03% increase from a year earlier, with the FY2025 full-year figure at $148.7 million, up 164.92% from the prior year.
• Other Operating Expenses fell to $25.8 million in Q1 2026 per ORGO's latest filing, from $321.4 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $321.4 million in Q4 2025 and bottomed at -$62.9 million in Q2 2024.
• The 4-year median for Other Operating Expenses is $29.4 million (2025), against an average of $50.1 million.
• Across the five-year window, Other Operating Expenses sank 82.78% in 2024 and jumped 1653.09% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $106.5 million in 2023, then sank by 82.78% to $18.3 million in 2024, then soared by 1653.09% to $321.4 million in 2025, then tumbled by 91.98% to $25.8 million in 2026.
• Per Business Quant, the three latest ORGO Other Operating Expenses figures stand at $25.8 million (Q1 2026), $321.4 million (Q4 2025), and $37.2 million (Q3 2025).